Page last updated: 2024-10-29

isradipine and A-V Dissociation

isradipine has been researched along with A-V Dissociation in 2 studies

Isradipine: A potent antagonist of CALCIUM CHANNELS that is highly selective for VASCULAR SMOOTH MUSCLE. It is effective in the treatment of chronic stable angina pectoris, hypertension, and congestive cardiac failure.

Research Excerpts

ExcerptRelevanceReference
"When isradipine was administered, at a given concentration, heart rate and contractility decreased proportionately."1.30Cardiac inotropic vs. chronotropic selectivity of isradipine, nifedipine and clevidipine, a new ultrashort-acting dihydropyridine. ( Gonon, A; Nordlander, M; Rydén, L; Segawa, D; Sjöquist, PO; Wang, QD, 1999)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kerin, NZ1
Hai, HH1
Samuel, P1
Segawa, D1
Sjöquist, PO1
Nordlander, M1
Wang, QD1
Gonon, A1
Rydén, L1

Trials

1 trial available for isradipine and A-V Dissociation

ArticleYear
Effect of multiple doses of oral isradipine on atrioventricular conduction in patients with first-degree atrioventricular block.
    American journal of therapeutics, 1998, Volume: 5, Issue:2

    Topics: Administration, Oral; Aged; Atrioventricular Node; Bundle-Branch Block; Calcium Channel Blockers; Do

1998

Other Studies

1 other study available for isradipine and A-V Dissociation

ArticleYear
Cardiac inotropic vs. chronotropic selectivity of isradipine, nifedipine and clevidipine, a new ultrashort-acting dihydropyridine.
    European journal of pharmacology, 1999, Sep-10, Volume: 380, Issue:2-3

    Topics: Animals; Calcium Channel Blockers; Cardiotonic Agents; Coronary Circulation; Dihydropyridines; Heart

1999